Please enable Javascript and disable ad blockers

Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Show me how to use this page

Viromed Medical AG Stock

Price

Target price

/ Tradegate WKN: A40ZVN / Name: Viromed Medical / Stock / ? /

Please give a prediction to see the opinions of the community

sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Your prediction

Financial data and news for Viromed Medical

sharewise wants to provide you with the best news and tools for Viromed Medical, so we directly link to the best financial data sources.

Financials

News

Broker

News

EQS-News: Viromed Medical AG: Update on the Planned Acquisition of relyon plasma GmbHPhoto, wide shot, wide-angle lens, Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png

EQS-News: Viromed Medical AG: Update on the Planned Acquisition of relyon plasma GmbH

EQS-News: Viromed Medical AG: Update on the Planned Acquisition of relyon plasma GmbH

0

EQS-News: Viromed Medical AG: Study on Cold Plasma Application in the Lung Successfully CompletedPhoto, wide shot, wide-angle lens, Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png

EQS-News: Viromed Medical AG: Study on Cold Plasma Application in the Lung Successfully Completed

EQS-News: Viromed Medical AG: Study on Cold Plasma Application in the Lung Successfully Completed

0

EQS-News: Viromed Medical AG significantly increases consolidated revenue in the 2025 financial year and achieves a positive net incomePhoto, wide shot, wide-angle lens, Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png

EQS-News: Viromed Medical AG significantly increases consolidated revenue in the 2025 financial year and achieves a positive net income

EQS-News: Viromed Medical AG significantly increases consolidated revenue in the 2025 financial year and achieves a positive net income

0

EQS-News: Viromed Medical AG signs exclusive distribution partnership with NEBU-TEC for PulmoPlas® with a focus on veterinary applicationsPhoto, wide shot, wide-angle lens, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png

EQS-News: Viromed Medical AG signs exclusive distribution partnership with NEBU-TEC for PulmoPlas® with a focus on veterinary applications

EQS-News: Viromed Medical AG signs exclusive distribution partnership with NEBU-TEC for PulmoPlas® with a focus on veterinary applications

0

EQS-News: Viromed Medical AG: ViroCAP® med successfully completes regulatory process as a Class IIa medical device – starting signal for market launch at the European Wound Congress 2026Photo, wide shot, wide-angle lens, Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png

EQS-News: Viromed Medical AG: ViroCAP® med successfully completes regulatory process as a Class IIa medical device – starting signal for market launch at the European Wound Congress 2026

EQS-News: Viromed Medical AG: ViroCAP® med successfully completes regulatory process as a Class IIa medical device – starting signal for market launch at the European Wound Congress 2026

0

EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026Photo, wide shot, wide-angle lens, Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png

EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026

EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026

0

EQS-News: Viromed Medical AG starts production of the OEM version of ViroCAP® for HELLMUT RUCK GmbHPhoto, wide shot, wide-angle lens, Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png

EQS-News: Viromed Medical AG starts production of the OEM version of ViroCAP® for HELLMUT RUCK GmbH

EQS-News: Viromed Medical AG starts production of the OEM version of ViroCAP® for HELLMUT RUCK GmbH

0

EQS-News: Viromed Medical AG receives funding approval from the Federal Ministry of Research, Technology and Space for the development of cold plasma technologyPhoto, wide shot, wide-angle lens, Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png

EQS-News: Viromed Medical AG receives funding approval from the Federal Ministry of Research, Technology and Space for the development of cold plasma technology

EQS-News: Viromed Medical AG receives funding approval from the Federal Ministry of Research, Technology and Space for the development of cold plasma technology

0

EQS-News: Viromed Medical AG: Anna Heinen appointed to the Supervisory BoardPhoto, wide shot, wide-angle lens, Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png

EQS-News: Viromed Medical AG: Anna Heinen appointed to the Supervisory Board

EQS-News: Viromed Medical AG: Anna Heinen appointed to the Supervisory Board

0

EQS-News: Viromed Medical AG signs letter of intent to acquire relyon plasma GmbH – Strategic step toward integrated platform for cold plasma technologyPhoto, wide shot, wide-angle lens, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png

EQS-News: Viromed Medical AG signs letter of intent to acquire relyon plasma GmbH – Strategic step toward integrated platform for cold plasma technology

EQS-News: Viromed Medical AG signs letter of intent to acquire relyon plasma GmbH – Strategic step toward integrated platform for cold plasma technology

0

EQS-Adhoc: Viromed Medical AG signs letter of intent to acquire relyon plasma GmbHPhoto, wide shot, wide-angle lens, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png

EQS-Adhoc: Viromed Medical AG signs letter of intent to acquire relyon plasma GmbH

EQS-Adhoc: Viromed Medical AG signs letter of intent to acquire relyon plasma GmbH

0